Two Sigma Investments
PTPI

Two Sigma Investments’s Petros Pharmaceuticals PTPI Stock Holding History

Two Sigma Investments’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-416
Closed -$162K – 2855
2022
Q1 		$162K Buy
+416
New +$175K ﹤0.01% 2369

Other funds holding PTPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
V
Veritable Wilmington, Delaware $6.46B AUM 17.32% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Two Sigma Investments's PTPI Position: Q2 2022 in Review

Two Sigma Investments sold out of Petros Pharmaceuticals (PTPI) in Q2 2022, closing a stake of 416 shares — an estimated $162K sold.

Two Sigma Investments first reported a position in PTPI in Q1 2022 and held it in 1 quarter. The position peaked at $162K in Q1 2022. 13 funds tracked by Wall St. Rank hold PTPI as of Q2 2022.

  • Two Sigma Investments reported no remaining Petros Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Investments sold 416 Petros Pharmaceuticals shares in Q2 2022, an estimated $162K.
  • Two Sigma Investments first reported a position in Petros Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Two Sigma Investments's Petros Pharmaceuticals position peaked at $162K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.